Aucatzyl is a CAR T-cell therapy that targets CD19 and has been designed to minimize excessive activation of the programmed T ...
Early Genetic Testing Avoids Treatment Delays for Patients with Friedreich's Ataxia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback